Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
6 participants
INTERVENTIONAL
2019-08-01
2020-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Gamified Digital Intervention to Enhance the Efficacy of Exposure Therapy for OCD
NCT05850312
Evaluation of an Intensive Inpatient Psychotherapy Treatment for Severely and Early Traumatized Children (MOSES)
NCT03894774
Dose Optimization of MDMA-Assisted Therapy for PTSD
NCT06418178
Multiphase Optimization Strategy (MOST) for Treating Pediatric Post-traumatic Stress Disorder (PTSD)
NCT06956781
High-Intensity Inpatient MDMA-Assisted Psychotherapy for PTSD
NCT06954025
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Method of Levels (MOL)
all participants will be offered intervention
psychological therapy Method of Levels (MOL)
Transdiagnostic, cognitive psychological therapy Method of Levels (MOL)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
psychological therapy Method of Levels (MOL)
Transdiagnostic, cognitive psychological therapy Method of Levels (MOL)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participants need to either meet ICD-10 criteria for schizophrenia, schizoaffective disorder and delusional disorder or meet entry criteria for an Early Intervention for Psychosis service.
Exclusion Criteria
* Known organic basis of symptoms
* Known lack of capacity to consent to participating in research
* Lack of fluency in English (since MOL therapy will be conducted in English and due to use of standardised assessment tools). This will be determined by the researcher.
* Acute inpatient status
* A primary diagnosis of a drug or alcohol dependency
* Concurrent psychological therapy.
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Manchester
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jadwiga Nazimek
Clinical Psychology Trainee
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
257300
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.